Kolistimetatnatrium Xellia vs Tadim: Side-by-Side Comparison
Quick answer: Kolistimetatnatrium Xellia and Tadim are both polymyxin antibiotic used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Kolistimetatnatrium Xellia | Tadim |
|---|---|---|
| Drug class | Polymyxin antibiotic | Polymyxin antibiotic |
| ATC code | J01XB01 | J01XB01 |
| Primary indications | Multidrug-resistant Gram-negative infections, Pseudomonas aeruginosa infections | Pseudomonas aeruginosa infections, Cystic fibrosis lung infections |
| Mechanism | Cationic polypeptide that disrupts bacterial outer membrane phospholipids causing cell death | Colistimethate sodium disrupts bacterial outer membrane lipopolysaccharide causing cell death |
| Common dose | 1-2 million IU IV every 8 hours (CMS); inhaled 1-2 million IU twice daily | 1-2 million IU 2-3 times daily (inhaled or IV) |
| Detail page | Kolistimetatnatrium Xellia details → | Tadim details → |
How to choose between Kolistimetatnatrium Xellia and Tadim
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Polymyxin antibiotic on iMedic · Kolistimetatnatrium Xellia full details · Tadim full details
Frequently asked questions
Is Kolistimetatnatrium Xellia better than Tadim?
Neither is universally 'better.' They are both polymyxin antibiotic with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Kolistimetatnatrium Xellia to Tadim?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Kolistimetatnatrium Xellia and Tadim have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Kolistimetatnatrium Xellia and Tadim available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.